FDA tentatively approves Merck's copycat of Sanofi's Lantus

(Reuters) - Merck and Co Inc said on Thursday the U.S. Food and Drug Administration (FDA) tentatively approved its biosimilar version of French drugmaker Sanofi SA's blockbuster diabetes treatment, Lantus.

Source: Reuters: Health - July 20, 2017 Category: Consumer Health News Tags: healthNews Source Type: news